Resumen de acción GALE
Galenica AG opera como proveedor de servicios sanitarios en Suiza y a escala internacional.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 1/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Competidores de Galenica AG
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | CHF70.25 |
| 52 Week High | CHF79.45 |
| 52 Week Low | CHF65.10 |
| Beta | 0.18 |
| 1 Month Change | -6.58% |
| 3 Month Change | -7.20% |
| 1 Year Change | -11.24% |
| 3 Year Change | 11.95% |
| 5 Year Change | 43.84% |
| Change since IPO | 63.37% |
Noticias y actualizaciones recientes
Galenica AG (VTX:GALE) Investors Are Less Pessimistic Than Expected
Apr 25
We Think The Compensation For Galenica AG's (VTX:GALE) CEO Looks About Right
Apr 04Slowing Rates Of Return At Galenica (VTX:GALE) Leave Little Room For Excitement
Mar 29Recent updates
Galenica AG (VTX:GALE) Investors Are Less Pessimistic Than Expected
Apr 25We Think The Compensation For Galenica AG's (VTX:GALE) CEO Looks About Right
Apr 04Slowing Rates Of Return At Galenica (VTX:GALE) Leave Little Room For Excitement
Mar 29Pinning Down Galenica AG's (VTX:GALE) P/E Is Difficult Right Now
Jan 22Is There An Opportunity With Galenica AG's (VTX:GALE) 42% Undervaluation?
Jan 04Returns On Capital At Galenica (VTX:GALE) Have Hit The Brakes
Oct 26Is Galenica (VTX:GALE) Using Too Much Debt?
Oct 11Are Investors Undervaluing Galenica AG (VTX:GALE) By 42%?
Sep 26These 4 Measures Indicate That Galenica (VTX:GALE) Is Using Debt Reasonably Well
Jun 20Here's What To Make Of Galenica's (VTX:GALE) Decelerating Rates Of Return
Apr 17We Think Galenica (VTX:GALE) Can Stay On Top Of Its Debt
Mar 12Returns On Capital At Galenica (VTX:GALE) Have Hit The Brakes
Jan 08These 4 Measures Indicate That Galenica (VTX:GALE) Is Using Debt Reasonably Well
Nov 28The Returns At Galenica (VTX:GALE) Aren't Growing
Sep 20Is Galenica (VTX:GALE) A Risky Investment?
Aug 30Return Trends At Galenica (VTX:GALE) Aren't Appealing
Jun 15Galenica (VTX:GALE) Could Easily Take On More Debt
Apr 06Galenica (VTX:GALE) Has More To Do To Multiply In Value Going Forward
Feb 15Should You Be Adding Galenica (VTX:GALE) To Your Watchlist Today?
Jan 02Does Galenica (VTX:GALE) Have A Healthy Balance Sheet?
Nov 30Returns At Galenica (VTX:GALE) Appear To Be Weighed Down
Oct 24With EPS Growth And More, Galenica (VTX:GALE) Is Interesting
Sep 25Galenica (VTX:GALE) Seems To Use Debt Quite Sensibly
Aug 24Galenica (VTX:GALE) Has More To Do To Multiply In Value Going Forward
Jul 24If You Like EPS Growth Then Check Out Galenica (VTX:GALE) Before It's Too Late
Jun 12Investors Met With Slowing Returns on Capital At Galenica (VTX:GALE)
Apr 07Galenica (VTX:GALE) Seems To Use Debt Quite Sensibly
Mar 25Galenica AG Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Mar 11Is Galenica AG (VTX:GALE) The Right Choice For A Smart Dividend Investor?
Feb 27Are Institutions Heavily Invested In Galenica AG's (VTX:GALE) Shares?
Jan 31
Galenica (VTX:GALE) Shareholders Have Enjoyed A 25% Share Price Gain
Jan 13Is Galenica (VTX:GALE) Likely To Turn Things Around?
Dec 25Is Galenica (VTX:GALE) A Risky Investment?
Dec 09Is Galenica AG (VTX:GALE) An Attractive Dividend Stock?
Nov 24Rentabilidad de los accionistas
| GALE | CH Healthcare | Mercado CH | |
|---|---|---|---|
| 7D | -1.1% | 1.0% | -1.4% |
| 1Y | -11.2% | -3.3% | -3.6% |
Rentabilidad vs. Industria: GALE obtuvo unos resultados inferiores a los del sector Swiss Healthcare , que el año pasado arrojó un rendimiento del -7.2%.
Rentabilidad vs. Mercado: GALE obtuvo unos resultados inferiores a los del mercado Swiss, que fue del -2.5% el año pasado.
Volatilidad de los precios
| GALE volatility | |
|---|---|
| GALE Average Weekly Movement | 2.1% |
| Healthcare Industry Average Movement | 5.1% |
| Market Average Movement | 3.5% |
| 10% most volatile stocks in CH Market | 7.2% |
| 10% least volatile stocks in CH Market | 2.0% |
Precio estable de las acciones: GALE no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de GALE (2%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1927 | 6,181 | Marc Werner | www.galenica.com |
Galenica AG opera como proveedor de servicios sanitarios en Suiza y a escala internacional. Opera a través de dos segmentos, Products & Care, y Logistics & IT. El segmento Products & Care gestiona farmacias y farmacias asociadas con las marcas Amavita, Sun Store y Coop Vitality.
Resumen de fundamentos de Galenica AG
| Estadísticas fundamentales de GALE | |
|---|---|
| Capitalización bursátil | CHF3.50b |
| Beneficios(TTM) | CHF164.92m |
| Ingresos (TTM) | CHF3.76b |
21.2x
Ratio precio-beneficio (PE)0.9x
Ratio precio-ventas (PS)¿Está GALE sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de GALE | |
|---|---|
| Ingresos | CHF3.76b |
| Coste de los ingresos | CHF3.29b |
| Beneficio bruto | CHF461.34m |
| Otros gastos | CHF296.43m |
| Beneficios | CHF164.92m |
Últimos beneficios comunicados
Dec 31, 2023
Próxima fecha de beneficios
Aug 06, 2024
| Beneficios por acción (BPA) | 3.31 |
| Margen bruto | 12.28% |
| Margen de beneficio neto | 4.39% |
| Ratio deuda/patrimonio | 33.2% |
¿Cómo se ha desempeñado GALE a largo plazo?
Ver rendimiento histórico y comparativa